2019–2020 HPUS Updates
2019–2020 HPUS Updates: Essential Information Companies Need to Know WHEN Thursday, June 18 1 PM EDT (12 pm CT, 11 am MT, 10 am PT) REGISTRATION Zoom WebinarRegister Now. WHO…
Homeopathic Shopper Panel in the Era of COVID-19
July 23, 2-3 p.m. EDT | During this engaging virtual event, we’ll dive into survey data (collected in early July 2020) from the natural moms who purchase our products most.
AAHP Virtual Summit: Developing HPUS Guidelines for FDA Compliance
Join the alliance of homeopathic manufacturers, pharmacists, and other qualified parties in the homeopathic community for this powerful one-day investment featuring in-depth presentations by experts specifically in the homeopathic industry.…
Poison Control in 2021: A Complimentary Informational Webinar for Homeopathic Product Safety Stakeholders
Join us to learn about Poison Control Center reports of exposure to homeopathic drug products, and how you can work with the National Capital Poison Center (NCPC).
AAHP Annual Membership Meeting
Join us for The American Association for Homeopathic Medicine's Annual Membership Meeting
State of Research for Homeopathy
Hear from the world’s leading researcher Rachel Roberts, BSc(Hons) MCH RSHom FSHom FFHom(Hon)
Chief Executive at London’s Homeopathy Research Institute.
2020-21 HPUS Update Webinar
This half-hour webinar will review additions and changes to monographs in the Homeopathic Pharmacopeia of the United States (HPUS), including revised attenuation levels, and updates to quality control methods and specifications. HPUS insider Eric Foxman provides a fresh glimpse a month after the HPCUS annual meeting on year-long projects being done behind-the-scenes and the status of the “technical gaps” work. Whether you manufacture or just market homeopathic drug products, the changed information in the HPUS has a bearing on your products’ compliance status. Regulatory and FDA review of homeopathic products over the past year support the critical importance of being current with the updates in the HPUS. These changes and updates may affect your business, your cGMP compliance, your products, and your long-term success in the market!
2021 AAHP Summit: Developing HPUS Guidelines for FDA Compliance, Part 2
Does your company experience a gap between 21 CFR cGMP requirements and the pragmatic realities of implementation for homeopathic drug products? AAHP, in partnership with the Homeopathic Pharmacopoeia Convention of the United States (HPCUS), has identified five technical gaps that are challenges for both industry and FDA inspectors. In a continuation of this industrywide, multi-year effort, the 2021 Summit will present:
• Concept Paper: Process Validation for Preparation of Hahnemannian Liquids
• White Paper: Control of Active Pharmaceutical Ingredients
• Views on these pharmaceutical quality issues and necessary compliance considerations by Richard Lostritto, PhD, Associate Director for Science, Office of Policy for Pharmaceutical Quality at FDA’s CDER.
AAHP Industry Reception and Award Presentation
The Union League of Philadelphia 1450 Sansom St, Philadelphia, PA, United StatesIN PERSON AT EXPO! Join us for this complimentary and in-person event at the historic Union League of Philadelphia, or view it virtually. Just a 5-block walk from Natural Products Expo East and a 10-minute cab ride from Amtrak’s 30th Street Station.
AAHP Semiannual Membership Meeting
Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addressed as necessary. Additionally, AAHP officers will provide updates on association projects. AAHP Members are encouraged to invite your government affairs team, quality assurance team, marketing team, R&D team, and CEO.